Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Xiang Min Researcher Activity Profile

Research Author Detailed Information 

profile photo of Xiang MinXiang min researcher

Xiang Min Publication Rate By Year

Xiang Min has published 1 paper(s) in 2005, 5 paper(s) in 2007, 2 paper(s) in 2008, for a total of 8 research publications in total.

Xiang X Min Author Information

LAST NAME: min

FIRST NAME: Xiang

INITIALS: x

AFFILIATION:

Papers

Xiang Min's Publication Record

  1. [Surgical treatment of schwannomas in brachial plexus] Year Published: 2005
  2. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice. Year Published: 2007
  3. Department of Geriatrics, First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  4. [Pathological analysis of pancreatic colloid carcinoma in 7 cases] Year Published: 2007
  5. Substrate and docking interactions in serine/threonine protein kinases. Year Published: 2007
  6. Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, USA. Elizabeth.Goldsmith@UTSouthwestern.edu
  7. Substrate and docking interactions in serine/threonine protein kinases. Year Published: 2007
  8. Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, USA. Elizabeth.Goldsmith@UTSouthwestern.edu
  9. Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor. Year Published: 2008
  10. Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
  11. Estimation of the optimal VV delay by an IEGM-based method in cardiac resynchronization therapy. Year Published: 2007
  12. St. Jude Medical CRMD, Sylmar, California, USA. xmin@sjm.com
  13. Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor. Year Published: 2008
  14. Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News